Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
From Morphological Imaging to Molecular Targeting: Implications to Preclinical Development

From Morphological Imaging to Molecular Targeting: Implications to Preclinical Development

Schweinfurth, Hermann
Dinkelborg, Ludger
Schwaiger, Markus

Hardcover

Series: Ernst Schering Foundation Symposium Proceedings, Book 48

Medical ReferenceGeneral Psychology

ISBN10: 3540201378
ISBN13: 9783540201373
Publisher: Springer
Published: Jun 16 2004
Pages: 196
Weight: 1.20
Height: 0.70 Width: 6.30 Depth: 9.40
Language: English
Because of the current progress in molecular medicine (genomics, proteomics), a plethora of new and often human-specific targets are being identified. These targets often play a significant role in the pathogenesis of diseases, and identifying them offers the potential for early diagnosis and intervention. An early in vivo validation of specific ligands binding to these targets in humans is needed to as- sess their potential for targeted imaging and radiotherapy. Further- VI Preface more, such validation studies may allow for a better understanding of the molecular processes underlying phannacologic activity and therefore for a more successful development of phannaceuticals in general. The purpose of the Ernst Schering Research Foundation (ESRF) Workshop 48 was to provide a forum for an open exchange on the state of the art in the early development of such radiophanna- ceuticals. Experts from academia, industry, and regulatory authori- ties were invited to give presentations on aspects covering the identi- fication of targets, preclinical studies on the safety of ligands, as well as their validation in human clinical trials. It was our intention to cover both the opportunities and the challenges that scientists in this field are facing. Radiopharmaceuticals are uniquely suitable for the above-men- tioned target validation studies.

1 different editions

Also available

Also from

Schwaiger, Markus

View All

Also in

Medical Reference

View All